Free shipping on all orders over $ 500

P505-15 hydrochloride

Cat. No. M2063

All AbMole products are for research use only, cannot be used for human consumption.

P505-15 hydrochloride Structure
Synonym:

PRT062607 hydrochloride; PRT-2607 hydrochloride; BIIB-057 hydrochloride

Size Price Availability Quantity
1mg USD 60  USD60 In stock
5mg USD 120  USD120 In stock
10mg USD 180  USD180 In stock
25mg USD 320  USD320 In stock
50mg USD 480  USD480 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

P505-15 (also known as PRT062607) is a highly specific and potent, orally bioavailable small molecule spleen tyrosine kinase (Syk) inhibitor (IC50 = 1 nM) with anti-Syk activity that is at least 80-fold greater than its affinity for other kinases. P505-15 potently inhibited B cell antigen receptor-mediated B cell signaling and activation (IC50 0.27 and 0.28 μM, respectively) and Fcε receptor 1-mediated basophil degranulation (IC50 0.15 μM) in human whole blood. Similar levels of ex vivo inhibition were measured after dosing in mice (Syk signaling IC50 0.32 μM). P505-15 (PRT062607) decreased cell viability in NHL and CLL. Oral administration of P505-15 produced dose-dependent anti-inflammatory activity in two rodent models of rheumatoid arthritis. In addition, combination treatment of primary CLL cells with P505-15 plus fludarabine produced synergistic enhancement of activity at nanomolar concentrations.

Customer Product Validations & Biological Datas
Source J Pharmacol Exp Ther (2013). Figure 1. P505-15
Method flow cytometry
Cell Lines Ramos cells
Concentrations 2 μM
Incubation Time 72 h
Results These data are consistent with previous observations that P505-15 is a selective and potent inhibitor of Syk, with no appreciable activity against other BCR-related kinases
Chemical Information
Molecular Weight 429.91
Formula C19H23N9O.HCl
CAS Number 1370261-97-4
Solubility (25°C) DMSO 80 mg/mL
Water 80 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Spurgeon SE, et al. J Pharmacol Exp Ther. The selective SYK inhibitor P505-15 (PRT062607) inhibits B cell signaling and function in vitro and in vivo and augments the activity of fludarabine in chronic lymphocytic leukemia.

[2] Coffey G, et al. J Pharmacol Exp Ther. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.

Related Syk Products
GSK143 

GSK143 is an orally active and highly selective spleen tyrosine kinase (SYK) inhibitor with a pIC50 of 7.5.

PRT062607

PRT062607(P505-15; PRT-2607; BIIB-057) is a highly specific and potent inhibitor of Syk with IC50 of 1-2 nM; >80-fold selective for Syk than Fgr, Lyn, FAK, Pyk2 and Zap70.

GSK143 dihydrochloride 

GSK143 dihydrochloride is an orally active and highly selective spleen tyrosine kinase (SYK) inhibitor with a pIC50 of 7.5.

Syk Kinase Peptide Substrate

Syk Kinase Peptide Substrate is a Syk kinase peptide substrate.

TOP1288

TOP1288 is an SRC/Syk/p38α inhibitor for studies related to ulcerative colitis.

  Catalog
Abmole Inhibitor Catalog




Keywords: P505-15 hydrochloride, PRT062607 hydrochloride; PRT-2607 hydrochloride; BIIB-057 hydrochloride supplier, Syk, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.